GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » C21 Investments Inc (XCNQ:CXXI) » Definitions » 5-Year ROIIC %

C21 Investments (XCNQ:CXXI) 5-Year ROIIC % : 3.44% (As of Jan. 2023)


View and export this data going back to 1987. Start your Free Trial

What is C21 Investments 5-Year ROIIC %?

5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. C21 Investments's 5-Year ROIIC % for the quarter that ended in Jan. 2023 was 3.44%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for C21 Investments's 5-Year ROIIC % or its related term are showing as below:

XCNQ:CXXI's 5-Year ROIIC % is ranked worse than
50.16% of 951 companies
in the Drug Manufacturers industry
Industry Median: 3.48 vs XCNQ:CXXI: 3.44

C21 Investments 5-Year ROIIC % Historical Data

The historical data trend for C21 Investments's 5-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C21 Investments 5-Year ROIIC % Chart

C21 Investments Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
5-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.33 -1.62 40.41 11.65 3.44

C21 Investments Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Jun24 Sep24
5-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 20.12 - -

Competitive Comparison of C21 Investments's 5-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, C21 Investments's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


C21 Investments's 5-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, C21 Investments's 5-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where C21 Investments's 5-Year ROIIC % falls into.



C21 Investments 5-Year ROIIC % Calculation

C21 Investments's 5-Year ROIIC % for the quarter that ended in Jan. 2023 is calculated as:

5-Year ROIIC %=5-Year Incremental Net Operating Profit After Taxes (NOPAT)**/5-Year Incremental Invested Capital**
=( 1.7484552 (Jan. 2023) - -0.744 (Jan. 2018) )/( 72.516 (Jan. 2023) - 0.061 (Jan. 2018) )
=2.4924552/72.455
=3.44%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


C21 Investments  (XCNQ:CXXI) 5-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


C21 Investments 5-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of C21 Investments's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


C21 Investments Business Description

Traded in Other Exchanges
Address
601 West Cordova Street, Suite 170, Vancouver, BC, CAN, V6B 1G1
C21 Investments Inc is a vertically integrated cannabis company that cultivates, processes, and distributes quality cannabis and hemp-derived consumer products in the United States. The Company owns Silver State Relief and Silver State Cultivation in Nevada, including legacy Oregon brands Phantom Farms, Hood Oil and Eco Firma Farms. These brands produce and distribute a broad range of THC and CBD products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles.
Executives
Todd Andrew Harrison Director
Bruce Macdonald Director
Sky Pinnick Director
Leonard Werden Director
Michael Starrett Kidd Director, Senior Officer

C21 Investments Headlines

No Headlines